What does Alivus Life do?

Jun 06 2025 06:13 PM IST
share
Share Via
Alivus Life Sciences Ltd is a mid-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of 650 Cr and a net profit of 142 Cr for the quarter ending March 2025. Key metrics include a P/E ratio of 26.00 and a market cap of Rs 12,350 Cr.
Overview:
Alivus Life Sciences Ltd operates in the Pharmaceuticals & Biotechnology industry and is categorized as a Mid Cap company.

History:
Alivus Life Sciences Limited was initially established as 'Zorg Laboratories Private Limited' in 2011. The company was granted the Certificate of Incorporation by the Registrar of Companies, Maharashtra in Pune. The latest quarterly results reported net sales and net profit for the period ending March 2025.

Financial Snapshot:
Most recent Net Sales: 650 Cr (Quarterly Results - Mar 2025)
Most recent Net Profit: 142 Cr (Quarterly Results - Mar 2025)
Market-cap value: Rs 12,350 Cr (Mid Cap)

Key Metrics:
P/E: 26.00
Industry P/E: 35
Dividend Yield: 0.00%
Debt Equity: -0.17
Return on Equity: 19.13%
Price to Book: 4.91

Contact Details:
No Company Details Available
Registrar Address: Not available.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News